1-5 of 5
Kimberly B. Johansson
Close
Sort by
Journal Articles

Idasanutlin and Navitoclax Induce Synergistic Apoptotic Cell Death in T-Cell Acute Lymphoblastic Leukemia

Kimberly B. Johansson, Megan Gauthier, Feng Gao, Daniel C. Link
Journal: Blood
Blood (2022) 140 (Supplement 1): 3262–3263.
https://doi.org/10.1182/blood-2022-167220
Published: 2022
Journal Articles

Nucleolar Stress Plays a Key Role in the Pathogenesis of T Cell Acute Lymphoblastic Leukemia

Joseph R. Krambs, Kimberly B. Johansson, Isabelle Genter, Sai Mukund Ramakrishnan, Christopher A Miller, Daniel C. Link
Journal: Blood
Blood (2022) 140 (Supplement 1): 5891–5892.
https://doi.org/10.1182/blood-2022-158717
Published: 2022
Journal Articles

Targeting ATR in TP53 -Mutant AML/MDS

Jeremy T Baeten, Sumedha Agashe, Annabel Quinet, Kimberly B. Johansson, Alessandro Vindigni, Geoffrey L. Uy, Daniel C. Link
Journal: Blood
Blood (2022) 140 (Supplement 1): 8787–8788.
https://doi.org/10.1182/blood-2022-170238
Published: 2022
Journal Articles

TP53 Null AML Line Does Not Selectively Expand Under Lenalidomide Treatment

Kimberly B. Johansson, Jeremy T Baeten, Daniel C. Link
Journal: Blood
Blood (2021) 138 (Supplement 1): 4704.
https://doi.org/10.1182/blood-2021-148606
Published: 2021
Journal Articles

Evidence of Synergistic Effect of Idasanutlin and Navitoclax Using T-Cell Acute Lymphoblastic Leukemia Patient-Derived Xenografts

Kimberly B. Johansson, Megan Gauthier, MD, Feng Gao, MD PhD MPH, Daniel C. Link, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41.
https://doi.org/10.1182/blood-2020-139690
Published: 2020